Star
Star
Star
Star
Star
Star
Star
Solution

BD pipeline & outreach

We design and run targeted BD campaigns, qualifying and progressing conversations from first intro to term sheet.

Turning your partner thesis into a live pipeline

We take the asset and partnering strategy and turn it into a concrete BD engine. That means translating target lists into ranked accounts, mapping decision-makers, and driving structured outreach so you build a real pipeline of intros, meetings, NDAs, and active opportunities rather than ad-hoc conversations.

From target list to active conversations

We prioritise pharma, biotech, and investor targets by therapeutic focus, modality, geography, and deal appetite, then approach the right individuals with tailored narratives. Using a mix of warm BD&L access and well-prepared cold outreach, we coordinate intros, follow-ups, and conference touchpoints so momentum builds over time instead of stalling after a first email.

Building a repeatable BD engine

Alongside outreach, we set up a simple but disciplined pipeline view with stages, owners, and next actions. You see which opportunities are exploratory vs. serious, what’s blocking progress, and where additional data, internal alignment, or deal flexibility is needed to move to the next step.

Key areas of BD pipeline & outreach

  • Targeting & segmentation – Translating the partnering thesis into prioritised lists of companies and specific BD&L / therapeutic area contacts.

  • Outreach strategy & messaging – Crafting partner-specific outreach, follow-up sequences, and conference plans tied to key scientific and corporate milestones.

  • Meeting & funnel management – Coordinating intros, agendas, and follow-ups; tracking each opportunity from first contact to NDA, diligence, and term sheet.

  • Feedback & positioning loops – Capturing partner feedback systematically and feeding it back into messaging, evidence priorities, and deal scenarios.

  • Pipeline reporting & governance – Providing a clear overview for management with stages, probabilities, and next steps to support internal decision-making.

“Effective BD isn’t just ‘getting in front of people’—it’s running a disciplined pipeline where every conversation has a clear next step.”

With a structured BD pipeline and outreach approach, your team knows who to speak to, when to engage them, and how each conversation contributes to your overall partnering and deal objectives.

Turning your partner thesis into a live pipeline

We take the asset and partnering strategy and turn it into a concrete BD engine. That means translating target lists into ranked accounts, mapping decision-makers, and driving structured outreach so you build a real pipeline of intros, meetings, NDAs, and active opportunities rather than ad-hoc conversations.

From target list to active conversations

We prioritise pharma, biotech, and investor targets by therapeutic focus, modality, geography, and deal appetite, then approach the right individuals with tailored narratives. Using a mix of warm BD&L access and well-prepared cold outreach, we coordinate intros, follow-ups, and conference touchpoints so momentum builds over time instead of stalling after a first email.

Building a repeatable BD engine

Alongside outreach, we set up a simple but disciplined pipeline view with stages, owners, and next actions. You see which opportunities are exploratory vs. serious, what’s blocking progress, and where additional data, internal alignment, or deal flexibility is needed to move to the next step.

Key areas of BD pipeline & outreach

  • Targeting & segmentation – Translating the partnering thesis into prioritised lists of companies and specific BD&L / therapeutic area contacts.

  • Outreach strategy & messaging – Crafting partner-specific outreach, follow-up sequences, and conference plans tied to key scientific and corporate milestones.

  • Meeting & funnel management – Coordinating intros, agendas, and follow-ups; tracking each opportunity from first contact to NDA, diligence, and term sheet.

  • Feedback & positioning loops – Capturing partner feedback systematically and feeding it back into messaging, evidence priorities, and deal scenarios.

  • Pipeline reporting & governance – Providing a clear overview for management with stages, probabilities, and next steps to support internal decision-making.

“Effective BD isn’t just ‘getting in front of people’—it’s running a disciplined pipeline where every conversation has a clear next step.”

With a structured BD pipeline and outreach approach, your team knows who to speak to, when to engage them, and how each conversation contributes to your overall partnering and deal objectives.

We align BioPharma innovation, capital, and strategy cross borders.

We connect visionary researchers and impact-driven investors to shape the future of healthcare.

We align BioPharma innovation, capital, and strategy cross borders.

We connect visionary researchers and impact-driven investors to shape the future of healthcare.

We align BioPharma innovation, capital, and strategy cross borders.

We connect visionary researchers and impact-driven investors to shape the future of healthcare.

Logo

Deep domain expertise. Better BioPharma deals

Where Visionaries Shape The Future And Leave a Lasting Legacy

© Jarlen Capital powered by Sphere Corporate